First Case of Ovarian Metastases From a Primary Retroperitoneal Mucinous Carcinoma Associated With Teratoma, With KRAS and ERBB3 Mutations: Case Report and Literature Review.
AuteursFallas J, Salmon I, Maris C, Gómez Galdón M, D'Haene N, Noël JC, Catteau X
Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative.
AuteursRaicevic Toungouz G, Alessandrello R, Giacomini P, Kamal M, Gausachs M, Mazzarella L, Sujobert P, Frigè G, Alay A, Planchon JM, Blau O, Mias Carballal MR, Antoine-Poirel H, Nadal E, Bullinger L, Hebrant A, Servant N, D'Haene N, Aftimos P, Silkenstedt E, Michalík A, Dupain C, Delcourt T, Huet S, Van Campenhout C, Cordero D, Castellano Garcia JM, Codony C, Krol A, Gonzalo J, Van Damme N, Delnord M, Carbone R, Trapani V, Van Garsse S, Van Den Bulcke M
Wnt/β-catenin activation by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary basal cell adenoma.
AuteursWong K, Bishop JA, Weinreb I, Motta M, Del Castillo Velasco-Herrera M, Bellacchio E, Ferreira I, van der Weyden L, Boccacino JM, Lauri A, Rotundo G, Ciolfi A, Cheema S, Olvera-León R, Offord V, Droop A, Vermes I, Allgäuer M, Hyrcza M, Anderson E, Smith K, de Saint Aubain N, Mogler C, Stenzinger A, Arends MJ, Brenn T, Tartaglia M, Adams DJ
Development and Validation of an 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.
AuteursPaquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A
[18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.
AuteursChan DL, Hayes A, Karfis I, Conner A, Mileva M, Bernard E, Navalkissoor S, Gnanasekaran G, Clarke SJ, Roach PJ, Flamen P, Caplin ME, Pavlakis N, Toumpanakis C, Bailey DL
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial.
AuteursCollet L, Ardin M, Venet D, Berthet J, Ghamry-Barrin S, Treilleux I, Noel JC, Leheurteur M, Meunier J, Bengrine Lefevre L, Martinez M, Priou F, Selle F, Just PA, Bataillon G, Rothé F, Sotiriou C, Caux C, Dubois B, Ray-Coquard I, Le Saux O
